Skip to main content
. 2024 Sep 27;11:1447829. doi: 10.3389/fcvm.2024.1447829

Table 1.

Demographics and comorbidities of patients who underwent CTO-PCI.

Variable Failed CTO-PCI (N = 48) Successful CTO-PCI (N = 252) p-value
Mean age (±SD) 67.0 ±9.1 64.4 ±10.3 0.11
N % N %
Female 10 20.8 40 15.9 0.40
Smoking 26 54.2 133 52.8 0.86
Alcohol consumption 29 60.4 112 44.6 0.045*
Hypertension 36 75.0 186 74.1 0.90
Hyperlipidaemia 36 75.0 210 83.3 0.17
Familial hypercholesterolaemia 0 0.0 3 1.2 0.45
Diabetes mellitus 16 33.3 84 33.3 1.00
Diabetes status 1.00
Diet or no diabetes 33 68.8 173 69.2
Insulin 4 8.3 21 8.4
Oral 11 22.9 56 22.4
Previous myocardial infarction 22 45.8 124 49.2 0.67
Previous PCI 39 81.3 209 82.9 0.78
Previous CABG 7 14.6 27 10.7 0.44
Peripheral artery disease 14 29.2 25 9.9 <0.001*
Cerebrovascular disease 8 16.7 32 12.7 0.46
Previous stroke or TIA 4 8.3 13 5.2 0.38
COPD 9 18.8 27 10.7 0.12
Malignancy 9 18.8 35 13.9 0.38
Atrial fibrillation 5 10.4 31 12.3 0.71
Heart failure 17 35.4 74 30.1 0.47

SD, standard deviation; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; TIA, transient ischemic attack; COPD, chronic obstructive pulmonary disease. *p < 0.05.